+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid protects against experimental colon cancer



Ursodeoxycholic acid protects against experimental colon cancer



Gastroenterology 106(4 Suppl. ): A393




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144885

Download citation: RISBibTeXText


Related references

Effect of ursodeoxycholic acid in an experimental colon cancer model FT Efecto del acido ursodeoxicolico en un modelo experimental de cancer de colon. 2007

Ursodeoxycholic acid protects colon cancer HCT116 cells from deoxycholic acid-induced apoptosis by inhibiting apoptosome formation. Nutrition and Cancer 64(4): 617-626, 2012

Effect of ursodeoxycholic acid in an experimental colon cancer model. Revista Espanola de Enfermedades Digestivas 99(9): 491-496, 2007

Differential regulation of EGFR-MAPK signaling by deoxycholic acid (DCA) and ursodeoxycholic acid (UDCA) in colon cancer. Digestive Diseases and Sciences 59(10): 2367-2380, 2014

W1976 Opposing Effects of Deoxycholic Acid and Ursodeoxycholic Acid On Golgi Structure; Implications for Colon Cancer Progression. Gastroenterology 134(4): A-746, 2008

Chemoprevention of colon cancer by ursodeoxycholic acid a possible mechanism of action. Gastroenterology 108(4 Suppl. ): A463, 1995

Chemoprotective ursodeoxycholic acid, but not chemopromotional cholic acid, prevents the activation of PKC-beta-2 and PKC-zeta in the azoxymethane model of colon cancer. Gastroenterology 108(4 Suppl. ): A550, 1995

Ursodeoxycholic Acid (Udca) Can Inhibit Deoxycholic Acid (Dca)-induced Apoptosis via Modulation of Egfr/Raf-1/Erk Signaling in Human Colon Cancer Cells1. The Journal of Nutrition 134(2): 483-486, 2004

Ursodeoxycholic acid inhibits interleukin 1 beta [corrected] and deoxycholic acid-induced activation of NF-kappaB and AP-1 in human colon cancer cells. International Journal of Cancer 118(3): 532-539, 2006

Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells. Journal of Nutrition 134(2): 483-486, 2004

Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth. Plos one 12(7): E0181183, 2017

Differential effects of tumour promoting bile acid deoxycholic acid and chemoprotective ursodeoxycholic acid on protein kinase c beta 1, epsilon and delta and transcription factors, nf kappab and ap 1 in human colon cancer cells. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No S992, 2003

Ursodeoxycholic acid and piroxicam up-regulate MHC antigen expression in rat colonocytes during colon cancer development. Gastroenterology 106(4 Suppl. ): A433, 1994

Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of Ras, p38, and CCAAT/enhancer-binding protein. Nutrition and Cancer 60(3): 389-400, 2008

Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caco 2 cells. Cancer Letters 235(1): 141-146, 2006